Où docteurs et entreprises se rencontrent

Vous avez déjà un compte ?

Nouvel utilisateur ?

Mot de passe oublié


ABG-83654 Emploi Sénior
14/03/2019 CDD 12 Mois Salaire à négocier
Paris - Ile-de-France - France
Santé, médecine humaine, vétérinaire
Recherche et Développement


The Institut Necker-Enfants Malades (INEM), created in January 2014, is an international biomedical research center located on the Necker Hospital campus, and supported by the French National Institute of Health and Medical Research (INSERM), the French National Center for Scientific Research (CNRS) and the University Paris Descartes.

The close interaction between the research labs and the clinical departments is one of our major strengths creating a highly dynamic environment and promoting translational and “bench to bedside” activities.

The INEM is the hub for cellular and molecular biology at University Paris Descartes, one of the World's leading universities. The Institute draws together over 100 talented scientists who are working together to translate research discoveries into applied more effective diagnostics and therapies.

The post-holder will be based at INEM in the Circulating Rare Cells Research team within the “PRL/GH Pathophysiology: translational approaches" laboratory (Director: Dr Vincent Goffin) in the department of Cellular and Molecular Biology (INSERM Unit 1151). The Circulating Rare Cells Research team is working in a public/private partnership with the Company Rarecells Diagnostics. The post-holder will report directly to Professor Patrizia Paterlini-Bréchot, MD, PhD., inventor of the ISET® Technology for isolation and characterization of Circulating Tumor cells (CTC), internationally recognized by 80 independent scientific publications. 

Site web :

Poste et missions

The collaborative project, funded within Transcan-JTC 2016 and entitled CLEARLY: Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection aims to investigate mutations and transcript profiles of individual tumor cells circulating in blood of patients with lung cancer using advanced single cell-based molecular systems and advanced microscopy. The Researcher will also be involved in the development of single cell transcriptome analysis for the phenotypical study of circulating tumor cells contributing to unravel the mechanisms involved in tumor invasion.

Mobilité géographique :



Candidates for the advertised position should be holders of PhD, or MD or both degrees with experience in Molecular Biology, Cellular biology or Genetics and Single cell molecular analyses. The successful candidate is expected to be highly motivated, to work independently, to have good communication skills and to be interested in technology development with clinical impact. Full proficiency in English language is required.

Partager via

Vous avez déjà un compte ?

Nouvel utilisateur ?

Mot de passe oublié
Besoin d'informations ?

Vous souhaitez recevoir une ou plusieurs lettres d’information de l’ABG. Chaque mois des actualités, des offres, des outils, un agenda…